Literature DB >> 11427604

Pneumocystis carinii carriage among cystic fibrosis patients, as detected by nested PCR.

A Sing1, A M Geiger, M Hogardt, J Heesemann.   

Abstract

A total of 137 sputa from 95 consecutive cystic fibrosis (CF) patients undergoing routine bacteriological surveillance were analyzed for Pneumocystis carinii colonization using nested PCR. Seven of 95 patients (7.4%) were PCR positive, suggesting that P. carinii carriage may exist among CF patients due to their underlying pulmonary disease.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11427604      PMCID: PMC88220          DOI: 10.1128/JCM.39.7.2717-2718.2001

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  10 in total

1.  Absence of Pneumocystis carinii carriers among patients with cystic fibrosis.

Authors:  J M Varela; J Dapena; C Regordán; M Blanco; M A González de la Puente; E J Calderón
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1998-10       Impact factor: 3.267

Review 2.  Cystic fibrosis.

Authors:  B J Rosenstein; P L Zeitlin
Journal:  Lancet       Date:  1998-01-24       Impact factor: 79.321

3.  Pneumocystis carinii isolated from lung lavage fluid in an infant with cystic fibrosis.

Authors:  F H Royce; D A Blumberg
Journal:  Pediatr Pulmonol       Date:  2000-03

4.  Evaluation of diagnostic value and epidemiological implications of PCR for Pneumocystis carinii in different immunosuppressed and immunocompetent patient groups.

Authors:  A Sing; K Trebesius; A Roggenkamp; H Rüssmann; K Tybus; F Pfaff; J R Bogner; C Emminger; J Heesemann
Journal:  J Clin Microbiol       Date:  2000-04       Impact factor: 5.948

5.  Transmission of Pneumocystis carinii DNA from a patient with P. carinii pneumonia to immunocompetent contact health care workers.

Authors:  S L Vargas; C A Ponce; F Gigliotti; A V Ulloa; S Prieto; M P Muñoz; W T Hughes
Journal:  J Clin Microbiol       Date:  2000-04       Impact factor: 5.948

6.  Pneumocystis carinii in lungs of adults at autopsy.

Authors:  J A Esterly
Journal:  Am Rev Respir Dis       Date:  1968-05

7.  Pneumocystis carinii pneumonia.

Authors:  C L Vogel; M H Cohen; R D Powell; V T DeVita
Journal:  Ann Intern Med       Date:  1968-01       Impact factor: 25.391

8.  Pneumocystis carinii carriage in immunocompetent patients with primary pulmonary disorders as detected by single or nested PCR.

Authors:  A Sing; A Roggenkamp; I B Autenrieth; J Heesemann
Journal:  J Clin Microbiol       Date:  1999-10       Impact factor: 5.948

9.  Observations favouring Pneumocystis carinii pneumonia as a primary infection: a monoclonal antibody study on paraffin sections.

Authors:  P R Millard; A R Heryet
Journal:  J Pathol       Date:  1988-04       Impact factor: 7.996

10.  Pneumocystis carinii infection: evidence for high prevalence in normal and immunosuppressed children.

Authors:  L L Pifer; W T Hughes; S Stagno; D Woods
Journal:  Pediatrics       Date:  1978-01       Impact factor: 7.124

  10 in total
  17 in total

Review 1.  Fungal Pathogens in CF Airways: Leave or Treat?

Authors:  A Singh; A Ralhan; C Schwarz; D Hartl; A Hector
Journal:  Mycopathologia       Date:  2017-08-02       Impact factor: 2.574

2.  Prospective multicenter study of Pneumocystis jirovecii colonization among cystic fibrosis patients in France.

Authors:  Francisca Hernández-Hernández; Emilie Fréalle; Patrick Caneiro; Julia Salleron; Isabelle Durand-Joly; Isabelle Accoceberry; Jean-Philippe Bouchara; Benoit Wallaert; Eduardo Dei-Cas; Laurence Delhaes
Journal:  J Clin Microbiol       Date:  2012-09-26       Impact factor: 5.948

3.  Pneumocystis jirovecii testing by real-time polymerase chain reaction and direct examination among immunocompetent and immunosuppressed patient groups and correlation to disease specificity.

Authors:  John W Wilson; Andew H Limper; Thomas E Grys; Theresa Karre; Nancy L Wengenack; Matthew J Binnicker
Journal:  Diagn Microbiol Infect Dis       Date:  2011-02       Impact factor: 2.803

4.  Pneumocystis jirovecii and Cystic Fibrosis in Brittany, France.

Authors:  Gilles Nevez; Florence Robert-Gangneux; Laurence Pougnet; Michèle Virmaux; Chantal Belleguic; Eric Deneuville; Gilles Rault; Sylviane Chevrier; Sophie Ramel; Jean Le Bihan; Thibaud Guillaud-Saumur; Enrique Calderon; Yohann Le Govic; Jean-Pierre Gangneux; Solène Le Gal
Journal:  Mycopathologia       Date:  2017-07-07       Impact factor: 2.574

Review 5.  Pneumocystis colonization, airway inflammation, and pulmonary function decline in acquired immunodeficiency syndrome.

Authors:  Karen A Norris; Alison Morris; Sangita Patil; Eustace Fernandes
Journal:  Immunol Res       Date:  2006       Impact factor: 2.829

Review 6.  Colonization by Pneumocystis jirovecii and its role in disease.

Authors:  Alison Morris; Karen A Norris
Journal:  Clin Microbiol Rev       Date:  2012-04       Impact factor: 26.132

7.  Pneumocystis infection alters the activation state of pulmonary macrophages.

Authors:  Jessica M Deckman; Cathryn J Kurkjian; Joseph P McGillis; Theodore J Cory; Susan E Birket; Linda M Schutzman; Brian S Murphy; Beth A Garvy; David J Feola
Journal:  Immunobiology       Date:  2016-10-05       Impact factor: 3.144

8.  Pneumocystis jirovecii colonization is associated with enhanced Th1 inflammatory gene expression in lungs of humans with chronic obstructive pulmonary disease.

Authors:  Meghan E Fitzpatrick; John R Tedrow; Maria E Hillenbrand; Lorrie Lucht; Thomas Richards; Karen A Norris; Yingze Zhang; Frank C Sciurba; Naftali Kaminski; Alison Morris
Journal:  Microbiol Immunol       Date:  2014-03       Impact factor: 1.955

9.  Detection of Pneumocystis jirovecii by two staining methods and two quantitative PCR assays.

Authors:  P Rohner; V Jacomo; R Studer; J Schrenzel; J-D Graf
Journal:  Infection       Date:  2008-12-05       Impact factor: 3.553

10.  Risk Factors of Mortality From Pneumocystis Pneumonia in Non-HIV Patients: A Meta-Analysis.

Authors:  Yuqiong Wang; Xiaoyi Zhou; Maidinuer Saimi; Xu Huang; Ting Sun; Guohui Fan; Qingyuan Zhan
Journal:  Front Public Health       Date:  2021-06-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.